Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Mixed Open; Ashtead Leads Gainers, Worldpay Losers

Wed, 07th Sep 2016 07:33

LONDON (Alliance News) - Stocks in London were mixed after the open on Wednesday, with Ashtead Group leading the blue-chip gainers after a well-received update, while Worldpay Group was the worst performer after private equity firms sold more shares than planned in the payments company.

The FTSE 100 index was down 1.08 points at 6,824.97. The FTSE 250 was down 0.2% at 17,965.33 and the AIM All-Share was up 0.2% at 799.26.

Ashtead rose 5.3%. The equipment rental company said the weakness of sterling following the UK's European Union membership vote will mean its full-year results are likely outpace its current expectations, as it said first quarter profit and revenue grew.

Ashtead, which makes most of its money in the US in dollars but reports its results in sterling, said pretax profit for the quarter to the end of July grew to GBP177.9 million, from GBP155.4 million a year earlier, while revenue increased to GBP707.1 million from GBP618.6 million.

Fellow FTSE 100 constituent Barratt Developments was up 1.8%. The housebuilder said its sales trend since the end of June had been encouraging and underpinned a "business-as-usual" stance following the Brexit decision, as it reported a 21% rise in pretax profit for its financial year.

Barratt hiked its final dividend to 12.30 pence per share up from 10.3p per share. This, together with a 12.40p per share special dividend and the interim dividend, meant the full-year dividend offered was 30.70p per share, up from 25.10p per share the prior year.

Gold miners Randgold Resources and Fresnillo were up 1.8% and 1.6%, respectively, tracking the precious metal's price higher. Gold was quoted at USD1,350.52 an ounce after the open, compared to USD1,339.59 an ounce at the European equities close on Tuesday.

A decline in the dollar on Tuesday against other major currencies following weak services data from the US boosted the oil price overnight, with Brent crude quoted at USD47.67 a barrel against USD46.81 on Tuesday.

Shares in Worldpay Group were down 3.8%, the worst blue-chip performer, after private equity firms Advent International and Bain Capital sold a larger-than-planned stake in the payments company. The transaction was first announced just after the London close on Tuesday, when BofA Merrill Lynch said the two investors were planning to sell 300.0 million Worldpay shares, or around a 15% stake, which eventually ended being 350.0 million shares.

Fund supermarket Hargreaves Lansdown said its chief executive will step down by the end of September 2017, as it reported growth in profit, net revenue and assets under administration in its financial year to the end of June. The stock was down 1.4%.

Hargreaves also said pretax profit for the year to June 30 grew 10% year-on-year to GBP218.9 million from GBP199.0 million a year prior. It will pay a second interim dividend of 16.30 pence per share, taking its total payout for the year to 34.00p, up 3.0% from the 33.0p payout a year before.

In the FTSE 250, Vectura Group was the biggest mid-cap performer, up 6.7%. The company, which primarily focuses on treatments for inhaled airways disease, raised its revenue expectations for the nine months to end December 31, thanks to its current strong trading performance.

At the other end of the index, CMC Markets was down 12%. The online retail trading firm said it has continued to make progress in its current financial year so far but said a lack of volatility in markets will hit its net operating income in the first half.

Investors will keep an eye this morning on UK manufacturing and industrial production data and Bank of England Governor Mark Carney's testimony to the Treasury Select Committee of Parliament.

Lloyds Bank analyst Nikesh Sawjani expects UK industrial production to show a 0.2% rise in July versus the 0.1% growth seen in June, while he expects manufacturing production to rise 0.5% from the 0.3% decline a month ago. The data are scheduled for 0930 BST.

At 1000 BST, Carney will lead testimony to the Treasury Select Committee, which is holding hearings on the August 4 Quarterly Inflation Report.

The BoE drastically downgraded its growth projections at the Inflation Report as the Leave vote in the EU referendum heightened uncertainty, and the sharp depreciation in sterling triggered an upward revision to the inflation forecast. In addition, UK interest rates were cut by 25 basis points to 0.25%, the first rate cut since 2009, amid other easing measures to reassure investor's confidence.

"Despite signs that the UK economy may be holding up well, we expect Carney and other Monetary Policy Committee colleagues to remain circumspect in their appearance before the Treasury Select Committee," said Sawjani.

"Although the initial impact of the EU referendum has been less negative than had been feared, policymakers are likely to defend the forecasts in the August Inflation Report, which pointed to expectations of a marked slowdown in economic growth in the second half of the year. As such, officials will keep open the possibility of a further reduction in Bank Rate, with November as the earliest likely opportunity," noted the analyst.

In mainland Europe, the CAC 40 index in Paris and the DAX 30 in Frankfurt were both up 0.1%.

In Asia on Wednesday, the Japanese Nikkei 225 index ended down 0.4%. In China, the Shanghai Composite rose 0.1%, while the Hang Seng index in Hong Kong continues down 0.2%.

Elsewhere in the economic calendar, UK Halifax house prices are at 0930 BST. In the US, the Redbook index is at 1355 BST, while JOLTS job openings are at 1500 BST. The Fed's Beige Book is at 1900 BST, while API weekly crude oil stock data are at 2130 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
25 Jan 2017 07:48

Vectura sales trigger $5m milestone receipt

(ShareCast News) - Vectura said on Wednesday that a sales milestone receipt of $5m has been triggered following confirmation by Novartis that EU/Rest of World combined net sales of its Seebri Breezhaler and Ultibro Breezhaler for the year to the end of December have reached $512m. The milestone will

Read more
24 Jan 2017 08:21

Vectura gets FDA investigational approval for VR647

(ShareCast News) - Device and formulation business for inhaled airways disease, Vectura Group, announced on Tuesday it has received an 'Investigational New Drug' approval from the US Food and Drug Administration for its VR647 product. The FTSE 250 firm said the approval will allow it to conduct a Ph

Read more
24 Jan 2017 07:47

Vectura Gets US Approval For Phase I Trial Of Asthma Treatment

Read more
11 Jan 2017 08:25

Vectura makes 'significant progess' in third quarter

(ShareCast News) - Inhaled airways disease device and formulation business Vectura Group announced an unaudited pre-close update on Wednesday, ahead of its results for the nine months to 31 December, due in March. The FTSE 250 company said that following the step-change in financial performance anno

Read more
11 Jan 2017 07:58

Respiratory Medicine-Maker Vectura Breathing Easy Over Revenue Targets

Read more
23 Dec 2016 10:03

WINNERS & LOSERS SUMMARY: PayPoint Sale And Special Payout Lift Shares

Read more
23 Dec 2016 07:57

Vectura Group signs development agreement with Mundipharma

(ShareCast News) - Inhaled airways disease device and formulation business Vectura Group announced on Friday that it has signed a development and licence agreement with Mundipharma International Corporation and a US independent associated company as the global development and commercialisation partn

Read more
22 Dec 2016 14:57

Vectura says Bayer completes EU approval procedure for alternative nebulised delivery

(ShareCast News) - Vectura said on Thursday that its partner Bayer has confirmed completion of the EU regulatory procedure that allows an alternative nebulised delivery for its currently-marketed product Ventavis using the London-listed company's smart nebuliser Fox device. Ventavis has been develop

Read more
21 Dec 2016 14:15

Vectura says Novartis signs US licensing agreement for COPD treatments

(ShareCast News) - Vectura announced that Swiss pharmaceutical company Novartis has signed a licensing agreement with Sunovion Pharmaceuticals for the US commercialisation rights to three treatments for chronic obstructive pulmonary disease for which it receives royalty revenues. Novartis, whose pro

Read more
8 Dec 2016 07:57

Vectura confirms positive study results for Ultibro Breezhaler

(ShareCast News) - Inhaled airways disease-focused business Vectura Group confirmed an announcement by its partner Novartis on Thursday. The FTSE 250 firm said the announcement was of positive results from the first large-scale study exploring the effects of directly switching symptomatic, non-frequ

Read more
23 Nov 2016 07:40

Vectura earnings surge as Skyepharma merger creates step-change

(ShareCast News) - Inhaler maker Vectura's interim revenue have soared following the merger with rival Skyepharma and a launch of new products. For the six months ended 30 September, revenue increased 183% to £73.9m, compared to the same period last year, primarily due to the completion of the £441m

Read more
22 Nov 2016 07:41

TOP NEWS: Hikma Signs Development And Licensing Deal With Vectura

Read more
20 Nov 2016 15:57

Sunday newspaper round-up: OBR, Saudi Aramco, Tesco, BAT, bonds vigilantes

(ShareCast News) - The Office for Budget Responsibility is likely to cut its forecast for UK growth next year by the biggest margin since the peak of the eurozone debt crisis. Philip Hammond's Autumn Statement this week will see the Chancellor set out his multi-billion pound infrastructure plans and

Read more
17 Nov 2016 17:10

LONDON MARKET CLOSE: Strong US Data, Yellen Comments Point To Fed Hike

Read more
26 Oct 2016 14:14

Vectura climbs on positive read-across from Novartis, Singer upgrade

(ShareCast News) - Shares in medical device group Vectura were given a boost by expectations of foreign currency gains and investors reading across results from Novartis, with which the London-listed company is partnered on a handful of products. A third-quarter update from Novartis on Tuesday in

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.